234 related articles for article (PubMed ID: 21346244)
41. Kinin B1 Receptor Deletion Affects Bone Healing in Type 1 Diabetic Mice.
Cignachi NP; Pesquero JB; Oliveira RB; Etges A; Campos MM
J Cell Physiol; 2015 Dec; 230(12):3019-28. PubMed ID: 25969420
[TBL] [Abstract][Full Text] [Related]
42. Mice with a deletion in the gene for CCAAT/enhancer-binding protein beta are protected against diet-induced obesity.
Millward CA; Heaney JD; Sinasac DS; Chu EC; Bederman IR; Gilge DA; Previs SF; Croniger CM
Diabetes; 2007 Jan; 56(1):161-7. PubMed ID: 17192478
[TBL] [Abstract][Full Text] [Related]
43. CCAAT/enhancer-binding protein β (C/EBPβ) expression regulates dietary-induced inflammation in macrophages and adipose tissue in mice.
Rahman SM; Janssen RC; Choudhury M; Baquero KC; Aikens RM; de la Houssaye BA; Friedman JE
J Biol Chem; 2012 Oct; 287(41):34349-60. PubMed ID: 22902781
[TBL] [Abstract][Full Text] [Related]
44. Deficiency in the phosphatase PHLPP1 suppresses osteoclast-mediated bone resorption and enhances bone formation in mice.
Mattson AM; Begun DL; Molstad DHH; Meyer MA; Oursler MJ; Westendorf JJ; Bradley EW
J Biol Chem; 2019 Aug; 294(31):11772-11784. PubMed ID: 31189651
[TBL] [Abstract][Full Text] [Related]
45. The transcription factor CCAAT/enhancer-binding protein beta regulates gluconeogenesis and phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes.
Arizmendi C; Liu S; Croniger C; Poli V; Friedman JE
J Biol Chem; 1999 May; 274(19):13033-40. PubMed ID: 10224054
[TBL] [Abstract][Full Text] [Related]
46. Changes of CCAAT enhancer-binding proteins (CEBPs) in the lung of streptozotocin-induced diabetic rats.
Fong Y; Shen KH; Chen LJ; Cheng JT
Horm Metab Res; 2011 Apr; 43(4):261-7. PubMed ID: 21249617
[TBL] [Abstract][Full Text] [Related]
47. The Rho-GEF Kalirin regulates bone mass and the function of osteoblasts and osteoclasts.
Huang S; Eleniste PP; Wayakanon K; Mandela P; Eipper BA; Mains RE; Allen MR; Bruzzaniti A
Bone; 2014 Mar; 60():235-45. PubMed ID: 24380811
[TBL] [Abstract][Full Text] [Related]
48. C/EBPβ promotes BCR-ABL-mediated myeloid expansion and leukemic stem cell exhaustion.
Hayashi Y; Hirai H; Kamio N; Yao H; Yoshioka S; Miura Y; Ashihara E; Fujiyama Y; Tenen DG; Maekawa T
Leukemia; 2013 Mar; 27(3):619-28. PubMed ID: 22948537
[TBL] [Abstract][Full Text] [Related]
49. Isopsoralen-mediated suppression of bone marrow adiposity and attenuation of the adipogenic commitment of bone marrow-derived mesenchymal stem cells.
Wang J; Li SF; Wang T; Sun CH; Wang L; Huang MJ; Chen J; Zheng SW; Wang N; Zhang YJ; Chen TY
Int J Mol Med; 2017 Mar; 39(3):527-538. PubMed ID: 28204811
[TBL] [Abstract][Full Text] [Related]
50. Myeloid Lineage Ablation of
Karkache IY; Damodaran JR; Molstad DHH; Mansky KC; Bradley EW
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575866
[TBL] [Abstract][Full Text] [Related]
51. Post-transcriptional control of CCAAT/enhancer-binding protein beta (C/EBPbeta) expression: formation of a nuclear HuR-C/EBPbeta mRNA complex determines the amount of message reaching the cytosol.
Cherry J; Jones H; Karschner VA; Pekala PH
J Biol Chem; 2008 Nov; 283(45):30812-20. PubMed ID: 18678862
[TBL] [Abstract][Full Text] [Related]
52. Age-related marrow adipogenesis is linked to increased expression of RANKL.
Takeshita S; Fumoto T; Naoe Y; Ikeda K
J Biol Chem; 2014 Jun; 289(24):16699-710. PubMed ID: 24753250
[TBL] [Abstract][Full Text] [Related]
53. Curcumin suppresses increased bone resorption by inhibiting osteoclastogenesis in rats with streptozotocin-induced diabetes.
Hie M; Yamazaki M; Tsukamoto I
Eur J Pharmacol; 2009 Oct; 621(1-3):1-9. PubMed ID: 19699734
[TBL] [Abstract][Full Text] [Related]
54. Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate.
Dela Cruz A; Grynpas MD; Mitchell J
Am J Physiol Endocrinol Metab; 2016 May; 310(10):E811-20. PubMed ID: 27006198
[TBL] [Abstract][Full Text] [Related]
55. Role of osteogenic Dickkopf-1 in bone remodeling and bone healing in mice with type I diabetes mellitus.
Hildebrandt N; Colditz J; Dutra C; Goes P; Salbach-Hirsch J; Thiele S; Hofbauer LC; Rauner M
Sci Rep; 2021 Jan; 11(1):1920. PubMed ID: 33479403
[TBL] [Abstract][Full Text] [Related]
56. Regulation of adipocyte 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) by CCAAT/enhancer-binding protein (C/EBP) β isoforms, LIP and LAP.
Esteves CL; Kelly V; Bégay V; Man TY; Morton NM; Leutz A; Seckl JR; Chapman KE
PLoS One; 2012; 7(5):e37953. PubMed ID: 22662254
[TBL] [Abstract][Full Text] [Related]
57. Type I diabetic bone phenotype is location but not gender dependent.
Martin LM; McCabe LR
Histochem Cell Biol; 2007 Aug; 128(2):125-33. PubMed ID: 17609971
[TBL] [Abstract][Full Text] [Related]
58. Reduced trabecular bone mass and strength in mice overexpressing Gα11 protein in cells of the osteoblast lineage.
Dela Cruz A; Mattocks M; Sugamori KS; Grynpas MD; Mitchell J
Bone; 2014 Feb; 59():211-22. PubMed ID: 24308950
[TBL] [Abstract][Full Text] [Related]
59. Reciprocal roles of MSX2 in regulation of osteoblast and adipocyte differentiation.
Ichida F; Nishimura R; Hata K; Matsubara T; Ikeda F; Hisada K; Yatani H; Cao X; Komori T; Yamaguchi A; Yoneda T
J Biol Chem; 2004 Aug; 279(32):34015-22. PubMed ID: 15175325
[TBL] [Abstract][Full Text] [Related]
60. Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation.
Liu Y; Berendsen AD; Jia S; Lotinun S; Baron R; Ferrara N; Olsen BR
J Clin Invest; 2012 Sep; 122(9):3101-13. PubMed ID: 22886301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
